EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural basis for inhibition of Mycobacterium tuberculosis α-methylacyl-CoA racemase by 2-arylthiopropanoyl-CoA inhibitor analogs

Otsile O Mojanaga, Timothy J Woodman, Matthew D Lloyd, K Ravi Acharya

Journal of Biological Chemistry · 2025-12 · 301 (12) · 110848

DOI: 10.1016/j.jbc.2025.110848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-12. Verfasst von Otsile O Mojanaga und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Bath, Bath, United Kingdom. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Racemases and Epimerases, Bacterial Proteins, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Bath, Diamond Light Source.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-Methylacyl-CoA racemase (AMACR; P504S) is a pivotal enzyme involved in the β-oxidation of branched-chain fatty acids and bile acid intermediates, catalyzing the conversion between (2R)- and (2S)-2-methylacyl-CoA thioester epimers. The AMACR reaction enables downstream catabolism of these thioesters via stereospecific enzymes within the β-oxidation pathway. The AMACR homolog in Mycobacterium tuberculosis (MCR) has emerged as a tractable model for dissecting the mechanistic underpinnings of the racemization reaction and presents a promising therapeutic target given the pathogen's dependence on lipid metabolism for persistence and virulence. Previously, we reported the detailed molecular structure of wild-type MCR and in complex with a diverse set of acyl-CoA substrates. They revealed conserved active site residues that mediate substrate anchoring and epimerization and highlighted distinct molecular interactions that confer selectivity toward 2-methyl-branched substrates. Complementing these results, in this report, we present high-resolution structures for 2-arylthiopropanoyl-CoA inhibitors in complex with MCR and a comprehensive set of enzyme inhibition assays to delineate structure-activity relationships and probe competitive binding modes. Our findings underscore the importance of inhibitor side-chain branching and CoA anchoring in modulating enzymatic turnover and inhibition. Together, these data enhance our understanding of the racemization mechanism of MCR and establish a structural foundation for the rational design of selective inhibitors. Targeting MCR could represent a novel future therapeutic strategy for M. tuberculosis based on impairing cholesterol utilization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisRacemases and EpimerasesBacterial ProteinsEnzyme InhibitorsAcyl Coenzyme ACrystallography, X-RayCatalytic DomainStructure-Activity Relationship

Stichwörter der Autor:innen

2-arylthiopropanoyl-CoA inhibitorCoA-transferaseM. tuberculosisX-ray crystallographyibuprofenkinetic studyα-Methylacyl-CoA racemase (AMACR, P504S)

Substanzen

Racemases and Epimerasesalpha-methylacyl-CoA racemaseBacterial ProteinsEnzyme InhibitorsAcyl Coenzyme A

Autor:innen und Institutionen

  • Department of Life Sciences, University of Bath, Bath, United Kingdom.
  • Department of Life Sciences, University of Bath, Bath, United Kingdom. Electronic address: M.D.Lloyd@bath.ac.uk.
  • Department of Life Sciences, University of Bath, Bath, United Kingdom. Electronic address: bsskra@bath.ac.uk.

Förderung

  • University of Bath
  • Diamond Light Source

Zitieren

APA

Mojanaga, O. O., Woodman, T. J., Lloyd, M. D., & Acharya, K. R. (2025). Structural basis for inhibition of Mycobacterium tuberculosis α-methylacyl-CoA racemase by 2-arylthiopropanoyl-CoA inhibitor analogs. Journal of Biological Chemistry, 301(12), 110848. https://doi.org/10.1016/j.jbc.2025.110848

Vancouver

Mojanaga OO, Woodman TJ, Lloyd MD, Acharya KR. Structural basis for inhibition of Mycobacterium tuberculosis α-methylacyl-CoA racemase by 2-arylthiopropanoyl-CoA inhibitor analogs. Journal of Biological Chemistry. 2025;301(12):110848. doi:10.1016/j.jbc.2025.110848

BibTeX
@article{Mojanaga2025,
  author = {Mojanaga, Otsile O and Woodman, Timothy J and Lloyd, Matthew D and Acharya, K Ravi},
  title = {Structural basis for inhibition of Mycobacterium tuberculosis α-methylacyl-CoA racemase by 2-arylthiopropanoyl-CoA inhibitor analogs},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {12},
  pages = {110848},
  doi = {10.1016/j.jbc.2025.110848}
}
Kostenlos starten →